Allurion surges on weight loss data from gastric balloon, GLP-1 combo treatment
Allurion Technologies' gastric balloon and Novo Nordisk's semaglutide achieved 20.3% weight loss in a trial. Read more here.
Allurion Technologies’ gastric balloon+GLP1s may become new SOC, says Roth MKM
Roth MKM keeps a Buy rating and $16 price target on Allurion Technologies (ALUR) after its initial results from Allurion Program-GLP-1 combo.
Yahoo Finance26d
Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity
NATICK, Mass., March 04, 2025--(BUSINESS WIRE)--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today ...
Business Wire26d
Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity
The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less TM gastric balloon for weight loss with the ...
Investing10d
Allurion reports weight loss and muscle gain with new therapy
The Allurion Program includes a swallowable gastric balloon, which is part of a broader weight-loss platform that also features virtual care and a behavior change program. With revenue of $34.75 ...
ADVFN13d
Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity
The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-lessTM gastric balloon for weight loss, the Allurion ...
CNN3d
Allurion Technologies, Inc.
The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including ...
Investing10d
Allurion reports weight loss and muscle gain with new therapy
The Allurion Program includes a swallowable gastric balloon, which is part of a broader weight-loss platform that also features virtual care and a behavior change program. With revenue of $34.75 ...